Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P G Sluijter

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Advances in Experimental Medicine and Biology|September 23, 2017
Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac RepairE A Mol, M J Goumans, J P G Sluijter
Panminerva Medica|April 23, 2008
Stem cell sources for cardiac regenerationM Roccio, M J Goumans, J P G Sluijter, et al.
Mediators of Inflammation|January 7, 2014
Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptorsF van den Akker, S C A de Jager, J P G Sluijter
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Methods in molecular cardiology: quantitative real-time polymerase chain reactionJ P G Sluijter, M B Smeets, G Pasterkamp, et al.
Biochimica Et Biophysica Acta|September 15, 2012
Cardiac stem cell therapy to modulate inflammation upon myocardial infarctionF van den Akker, J C Deddens, P A Doevendans, et al.
Current Pharmaceutical Design|July 20, 2005
Modulation of collagen turnover in cardiovascular diseaseJ A Rodriguez-Feo, J P G Sluijter, D P V de Kleijn, et al.
Current Genomics|June 19, 2015
Heart Failure in Chronic Myocarditis: A Role for microRNAs?P van den Hoogen, F van den Akker, J C Deddens, et al.
Current Opinion in Organ Transplantation|July 23, 2009
Stem cell therapy for end-stage heart failure: indispensable role for the cell?K R Vrijsen, S A J Chamuleau, W A Noort, et al.
Atherosclerosis|September 25, 2007
Atherosclerotic lesion development and Toll like receptor 2 and 4 responsivenessA H Schoneveld, I Hoefer, J P G Sluijter, et al.
Panminerva Medica|March 16, 2010
Mesenchymal stromal cells to treat cardiovascular disease: strategies to improve survival and therapeutic resultsW A Noort, D Feye, F Van Den Akker, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|September 23, 2017
Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac RepairE A Mol, M J Goumans, J P G Sluijter
Panminerva Medica|April 23, 2008
Stem cell sources for cardiac regenerationM Roccio, M J Goumans, J P G Sluijter, et al.
Mediators of Inflammation|January 7, 2014
Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptorsF van den Akker, S C A de Jager, J P G Sluijter
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Methods in molecular cardiology: quantitative real-time polymerase chain reactionJ P G Sluijter, M B Smeets, G Pasterkamp, et al.
Biochimica Et Biophysica Acta|September 15, 2012
Cardiac stem cell therapy to modulate inflammation upon myocardial infarctionF van den Akker, J C Deddens, P A Doevendans, et al.
Current Pharmaceutical Design|July 20, 2005
Modulation of collagen turnover in cardiovascular diseaseJ A Rodriguez-Feo, J P G Sluijter, D P V de Kleijn, et al.
Current Genomics|June 19, 2015
Heart Failure in Chronic Myocarditis: A Role for microRNAs?P van den Hoogen, F van den Akker, J C Deddens, et al.
Current Opinion in Organ Transplantation|July 23, 2009
Stem cell therapy for end-stage heart failure: indispensable role for the cell?K R Vrijsen, S A J Chamuleau, W A Noort, et al.
Atherosclerosis|September 25, 2007
Atherosclerotic lesion development and Toll like receptor 2 and 4 responsivenessA H Schoneveld, I Hoefer, J P G Sluijter, et al.
Panminerva Medica|March 16, 2010
Mesenchymal stromal cells to treat cardiovascular disease: strategies to improve survival and therapeutic resultsW A Noort, D Feye, F Van Den Akker, et al.
Pageof 3